Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:appearance |
white crystalline solid
|
| gptkbp:ATCCode |
N03AA01
|
| gptkbp:boilingPoint |
1435 °C
|
| gptkbp:CASNumber |
7758-02-3
|
| gptkbp:category |
anticonvulsants
bromides potassium compounds |
| gptkbp:chemicalFormula |
KBr
|
| gptkbp:countryOfOperation |
worldwide
|
| gptkbp:density |
2.75 g/cm³
|
| gptkbp:discoveredBy |
gptkb:Jean-Baptiste_Boussingault
|
| gptkbp:discoveredIn |
1835
|
| gptkbp:EC_number |
231-830-3
|
| https://www.w3.org/2000/01/rdf-schema#label |
Potassium Bromide
|
| gptkbp:IUPACName |
gptkb:Potassium_bromide
|
| gptkbp:meltingPoint |
734 °C
|
| gptkbp:molecularWeight |
119.002 g/mol
|
| gptkbp:PubChem_CID |
24446
|
| gptkbp:relatedTo |
gptkb:Potassium_chloride
Sodium bromide |
| gptkbp:riskFactor |
H319 (causes serious eye irritation)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:solubility |
high
|
| gptkbp:UNNumber |
1814
|
| gptkbp:uses |
photography
laboratory reagent medicine (anticonvulsant) |
| gptkbp:bfsParent |
gptkb:Epileptic_Dogs
|
| gptkbp:bfsLayer |
6
|